Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.
Star Therapeutics has raised $125.0M in total funding. The most recent round was Series D. The last funding was announced in September 2025.
Star Therapeutics's investors include OrbiMed, Blue Owl, RA Capital Management, Cormorant Asset Management, Catalio Capital Management.
Star Therapeutics is headquartered in South San Francisco, United States.
Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.
Star Therapeutics is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Star Therapeutics — Funding & Investors." VCBacked, September 30, 2025, https://www.vcbacked.co/company/star-therapeutics. Accessed July 19, 2026.
VCBacked. (2025). Star Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/star-therapeutics
{{cite web |title=Star Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/star-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated